Neurocrine(NBIX) - 2023 Q4 - Earnings Call Transcript

Neurocrine Biosciences Inc. (NASDAQ:NBIX) Q4 2023 Earnings Conference Call February 7, 2024 8:00 AM ET Company Participants Kevin Gorman - Chief Executive Officer Matt Abernethy - Chief Financial Officer Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Kyle Gano - Chief Business Development and Strategy Officer Todd Tushla - Vice President, Investor Relations Conference Call Participants Paul Matteis - Stifel Tazeen Ahmad - Bank of America Brian Skorney - Baird Phil Nadeau - T ...